First Solar, Inc.

Executive Summary

BUY, Medium conviction. FSLR rates a BUY at Medium conviction. The setup is attractive because the stock is priced at 12.35x FY2025 EPS, below the 15.6x peer average, even as the company posts 32.9% operating margin, carries $1.7B net cash, and has visibility from a $13.6B backlog through 2030. The catch is that FY2026 guidance was left unchanged after a strong Q2, so the case depends on bookings conversion, policy clarity, and South Carolina ramp execution rather than a clean near-term raise cycle.

Investment Thesis

The stock is discounting too much deterioration for a business that still looks structurally advantaged in U.S. utility solar. FSLR trades at 12.35x FY2025 EPS of $14.25, below the 15.6x peer average, despite posting 32.9% operating margin and 29.7% net margin in FY2025. That is not a distressed business. It is a profitable manufacturer with a strong domestic position, a backlog of 45.1 GW worth $13.6B, and a balance sheet that management says holds $1.7B net cash. The market is paying a discount multiple for a company whose domestic fleet is substantially committed through 2028.

The case depends on three things. First, earnings durability. Q2 2026 adjusted EBITDA reached $644M at a 61.0% margin, and management guided Q3 adjusted EBITDA to $625M-$775M on 3.9-4.5 GW of volume. Some of that strength was helped by policy-linked items, including an $89M net IEPA tariff benefit in Q2, so this is not a clean extrapolation. But even after adjusting for that, current profitability is far above what the stock price implies. Second, bookings need to keep moving. FSLR added 1.9 GW of U.S. gross bookings at about $0.36/W since the last call, and management said, "there is demand that is still sitting there on the sidelines." If policy uncertainty clears, that sidelined demand can convert into visible revenue and support the next leg of the stock.

Third, capacity expansion and technology have to stay on track. South Carolina phase 1 remains set for 2H26, while phase 2 moved to mid-2027 to bring CuRe in earlier. That slip is not ideal, but CuRe is reportedly exceeding expectations in manufacturing and field deployments, which matters because technology credibility and field performance are the moat in utility solar. The weak spot in the thesis is cash conversion, with FY2025 FCF at -$0.3B, plus a mixed earnings track record with 4 misses in the last 8 quarters. That is why conviction is Medium. Still, at 40.2% below the 52-week high and 15.5% below the 200-day average, the setup already reflects a lot of skepticism. It does not require perfection to work from here.

Key Metrics

Financial Strength

The balance sheet is a clear strength. Leverage is minimal at 0.02 debt/equity and 0.09 debt/EBITDA, liquidity is solid with a 2.52 current ratio, and management said net cash stands at $1.7B. That gives FSLR room to fund South Carolina expansion and absorb policy noise without stressing the capital structure. The main blemish is cash conversion, with FY2025 free cash flow at -$0.3B despite high margins, so the question is not solvency but whether heavy investment and working capital normalize into consistently positive cash generation.

Competitive Position

FSLR's moat is unusually tangible for solar. It is one of the few scaled U.S. manufacturers with utility-grade bankability, a domestic footprint that is substantially committed through 2028, and a backlog stretching to 2030. Its thin-film platform and CuRe roadmap matter because technology differentiation is increasingly tied to delivered energy yield, heat performance, and supply-chain compliance, not just nameplate price. The moat is durable if U.S. trade and sourcing rules keep favoring domestic supply, but less durable if policy support weakens or if imported crystalline silicon regains a clear cost advantage after current trade frictions fade.

Management & Guidance

Management execution is good enough to support a BUY, but not clean enough for High conviction. The recent scorecard improved with beats of +35.2% and +6.3% in the last two reported quarters, and CFO Alexander Bradley said, "Adjusted EBITDA was $644 million, above the high end of our previously communicated Q2 preview range, with an adjusted EBITDA margin of 61%." That said, the company also has 4 misses in the last 8 quarters, including two large misses in early 2025, and the market noticed that "Our full year 2026 guidance remains unchanged." The South Carolina plan remains mostly intact with phase 1 in 2H26, but phase 2 moved to mid-2027, which supports a view that management is credible but not flawless.

Bull Case

• FY2025 revenue reached $5.2B, up 13.1% YoY, while EPS grew to $14.25, showing FSLR can still grow profitably at scale.
• The balance sheet is a real asset, with debt/equity 0.02, debt/EBITDA 0.09, current ratio 2.52, and management citing $1.7B net cash.
• Commercial visibility is stronger than the stock implies, with domestic fleet output substantially committed through 2028 and deliveries extending through 2030.
• Recent execution has improved, with EPS beats in 3 of the last 4 reported quarters, including +35.2% in July 2026 and +6.3% in April 2026.

Bear Case

• Management did not raise FY2026 guidance after a strong Q2, and explicitly said, "Our full year 2026 guidance remains unchanged." That tempers confidence that Q2 strength fully carries forward.
• A meaningful slice of current economics is policy-linked, including a $60M-$80M net tariff impact in FY2026 and an $89M net IEPA tariff benefit in Q2 gross margin.
• Free cash flow was -$0.3B in FY2025, so the story is not yet translating cleanly into cash generation despite high accounting margins.
• Execution is not spotless, with 4 misses in the last 8 quarters, including misses of -24.1%, -22.0%, and -7.3%, and South Carolina phase 2 slipping to mid-2027.

Valuation & Price Target

Engine price target $249.1 (+29.8% vs current), Medium confidence.

• P/E Multiple: $298.3 (28% weight)
• PEG (growth-adjusted): $319.51 (20% weight)
• P/S Multiple: $130.02 (20% weight)
• Quality-adjusted: $228.89 (20% weight)

The rating stays aligned with the quant baseline BUY and its $249.1 target. That makes sense because the stock is cheap on earnings at 12.35x versus 15.6x peers, balance sheet risk is low with a 33/100 risk score and $1.7B net cash, and the company still has backlog and margin support that most peers lack. Conviction remains Medium, not High, because the peer set has 3.6x dispersion, FY2026 guidance was not raised after a beat, and some recent margin strength was helped by tariff-related items. Analyst consensus is also bullish, but that is only a secondary cross-check, not the basis of the call.

Risk Assessment

Risk score 33/100 (Low). The biggest risk is that current earnings power proves too dependent on policy and tariff support, with FY2026 absorbing a $60M-$80M net tariff impact and customer decisions still delayed by Section 232 and FEOC uncertainty.

The Bottom Line

Rated BUY, Medium conviction. The stock is pricing FSLR more like a cyclical manufacturer than a high-margin, net-cash domestic solar platform with a $13.6B backlog and capacity largely spoken for through 2028. The unchanged FY2026 guide and policy-linked earnings support keep this from being a table-pounding call, but at 12.35x earnings and 40.2% off the high, the downside appears better reflected than the medium-term upside. Conviction would rise on a guidance increase, stronger bookings conversion, and improving free cash flow. It would fall if tariff benefits fade faster than expected, South Carolina slips again, or backlog quality starts to erode.